跳至主要内容
临床试验/CTRI/2020/05/024995
CTRI/2020/05/024995尚未招募未知

A STUDY TO EVALUATE THE HEPATOPROTECTIVE EFFECT OF N - ACETYLCYSTEINE ON ANTI TUBERCULOSIS DRUG INDUCED HEPATOTOXICITY AND QUALITY OF LIFE.

Dr Deepasree Sukumaran0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Newly diagnosed with pulmonary or extrapulmonary tuberculosis based on symptoms, radiological features and/or laboratory evidence and requiring first line ATT.
  • 2.LFT values less than or equal to 3 times of the normal reference values (SGOT less than or equal to 105 U/L, SGPT less than or equal to 120 U/L, ALP less than or equal to 390 U/L) and Total bilirubin less than or equal to 2 mg/dl).
  • 3. Subjects who agree to comply with the study procedures

排除标准

  • 1.Pregnant and lactating women.
  • 2.History of hypersensitivity to the study drug.
  • 3.Subjects with history of liver disease, kidney disease, COPD, asthma and HIV.
  • 4.History of chronic smoking or chronic alcoholism.
  • 5.Patients on any concomitant medications known to affect hepatic function within the past 3 months.
  • 6.Patients with any comorbidities that is known to affect the study outcome.
  • 7.Patients with any contraindications to the study medications.

研究者

发起方
Dr Deepasree Sukumaran

相似试验